BofA raised the firm’s price target on Texas Instruments (TXN) to $190 from $175 and keeps a Neutral rating on the shares. TI’s small Q1 beat and inline but sequentially rising Q2 sales guidance, “while modest, potentially marks a recovery inflection in industrial chip demand,” with positive read-across for U.S. peers such as Analog Devices (ADI), Microchip (MCHP), NXP Semiconductors (NXPI) and On Semiconductor (ON), the analyst tells investors. However, despite an expected recovery, TI’s sustained high capex intensity could keep reported calendar year 2024-26 pro-forma EPS below $6 per share, the analyst added.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TXN:
- TI reports first quarter 2024 financial results and shareholder returns
- Nvidia initiated, AMD upgraded: Wall Street’s top analyst calls
- Texas Instruments initiated with an Outperform at Evercore ISI
- Taiwan Earthquake: Will Chip Supply Be Impacted?
- China Urges EV Producers to Opt for Locally Made Chips